Hematology

Aston Health has a significant experience in implementing projects in Hematology (clinical registries, observational studies, etc.). For instance, together with the National Research Center for Hematology and the National Society for Hematology we have launched a National Registry of Blood Disorders.

The list of conditions that we cover in our research includes:

• Atypical hemolytic-uremic syndrome
• Gaucher disease
• Inhibitory hemophilia
• Myeloproliferative diseases (MPD)
• Multiple myeloma
• Acute lymphoblastic leukemia (ALL)
• Paroxysmal nocturnal hemoglobinuria
• Primary immune thrombocytopenia
• Chronic lymphocytic leukemia (CLL)
• Chronic myeloid leukemia (CML)

Projects currently underway include:

• Observational study in patients with ALL
• Registry of Patients with Gaucher disease
• Registry of Patients with PNH
• Registry of Patients with Primary Immune Thrombocytopenia
• Registry of Patients with Inhibitory Hemophilia
• Registry of Patients with Multiple Myeloma
• Registry of Patients with MPD
• Registry of Patients with CML
• Registry of Patients with CLL

We rely on the expert guidance of KOLs and the leading medical centers in Hematology, including:

• National Society for Hematology
• National Research Center for Hematology
• Moscow City Hematology Center n.a. Botkin

You can ask a question or forward a proposal to Elena Zhludova, Head of Hematology Department, Aston Health at e.zhludova@aston-health.com